| Patents for A61K 9 - Medicinal preparations characterised by special physical form (299,044) |
|---|
| 09/11/2002 | EP1238644A1 Stabilizers for l-ascorbic acid-2-sodium phosphate |
| 09/11/2002 | EP1237988A1 Method for producing nanoparticulate chitosans or chitosan derivatives |
| 09/11/2002 | EP1237878A2 4-pyrimidinyl-n-acyl-l-phenylalanines |
| 09/11/2002 | EP1237872A1 Compounds and compositions for delivering active agents |
| 09/11/2002 | EP1237854A1 Comminuted form of (s)-2-ethoxy -3- 4-(2- 4-methanesulfonyloxyphenyl ethoxy) phenyl] propanoic acid |
| 09/11/2002 | EP1237703A1 Device and method for producing solid shapes containing an active ingredient |
| 09/11/2002 | EP1237698A2 Water unstable foam compositions |
| 09/11/2002 | EP1237585A1 Mineral-polymer hybrid composition |
| 09/11/2002 | EP1237581A1 Use of cationic lipids for intracellular protein delivery |
| 09/11/2002 | EP1237577A2 Transmucosal composition containing a phosphodiesterase inhibitor for the treatment of erectile dysfunction |
| 09/11/2002 | EP1237573A1 Use of inactivated immunosuppressive or angiogenic immunogenic proteins for producing secretory iga's |
| 09/11/2002 | EP1237564A1 Inducing cellular immune responses to p53 using peptide and nucleic acid compositions |
| 09/11/2002 | EP1237561A2 Use of honey in medical dressings |
| 09/11/2002 | EP1237557A1 Galenical preparations of dapsone and related sulphones, and method of therapeutic and preventative treatment of disease |
| 09/11/2002 | EP1237556A2 Pharmaceutical implant containing immediate-release and sustained-release components and method of administration |
| 09/11/2002 | EP1237555A2 Implant composition containing melengestrol acetate and trenbolone acetate |
| 09/11/2002 | EP1237551A1 Pharmaceutical formulations containing zolmitriptan |
| 09/11/2002 | EP1237549A1 Lipoxin a4 and its analogs for the treatment of dry eye |
| 09/11/2002 | EP1237544A1 System and method for extended delivery of a therapeutic agent with its receptor loading dose |
| 09/11/2002 | EP1237543A1 Effervescent histamine h2 antagonist composition |
| 09/11/2002 | EP1237541A2 Liposomes |
| 09/11/2002 | EP1237540A2 Pharmaceutical gel and aerosol formulations and methods to administer the same to skin and mucosal surfaces |
| 09/11/2002 | EP1237539A1 Oral solution containing galanthamine and a sweetening agent |
| 09/11/2002 | EP1237538A2 An improved pharmaceutical composition for treating male erectile dysfunction |
| 09/11/2002 | EP1237537A1 Composition in the form of a gel for receiving an active ingredient in a solution or suspension, especially for application on a mucous membrane and method of production thereof |
| 09/11/2002 | EP1237423A1 Stable, spray-dried composition in a carbohydrate substrate and process for obtaining said composition |
| 09/11/2002 | EP1237408A2 Pour-on formulations |
| 09/11/2002 | EP1207908A4 Method of treating body insect infestation |
| 09/11/2002 | EP1100463B1 New injectable formulations containing ramoplanin |
| 09/11/2002 | EP1091775B1 Diphasic injection composition, in particular useful in reparative and plastic surgery |
| 09/11/2002 | EP1067936B1 Formulation of fast-dissolving efavirenz capsules or tablets using super-disintegrants |
| 09/11/2002 | EP1049480B1 Herbal anti-viral agent |
| 09/11/2002 | EP1047409B1 Tts containing an antioxidant |
| 09/11/2002 | EP1003490B1 Transdermal therapeutic system (tts) for administering sexual steroid hormones |
| 09/11/2002 | EP1001811B1 Nanoscale particles having an iron oxide-containing core enveloped by at least two shells |
| 09/11/2002 | EP0971704B1 Comestible capsules having flavoured coatings |
| 09/11/2002 | EP0956002A4 Delivery and activation through liposome incorporation of diaminocyclohexane platinum(ii) complexes |
| 09/11/2002 | EP0930873B1 Pharmaceutical gel preparation applicable to mucosal surfaces and body tissues |
| 09/11/2002 | EP0910399B1 Stable pharmaceutical composition of bdnf |
| 09/11/2002 | EP0904089B1 Sterilization of female mammals |
| 09/11/2002 | EP0893999B1 Process for producing efonidipine hydrochloride preparations |
| 09/11/2002 | EP0871467B1 Formulation for peptide release |
| 09/11/2002 | EP0862433B1 Topical foamable pharmaceutical composition for treating skin diseases induced by oval pityrosporum |
| 09/11/2002 | EP0840603B1 Pharmaceutical composition of l-dopa ethyl ester |
| 09/11/2002 | EP0831775B1 Sustained release ophthalmic emulsions |
| 09/11/2002 | EP0822847B1 COMPOSITION FOR ENHANCING ELECTROTRANSPORT AGENT DELlVERY |
| 09/11/2002 | EP0812235B1 Method for making granules, and resulting granules |
| 09/11/2002 | EP0808161B1 Solid substances comprising valproic acid and sodium valproate |
| 09/11/2002 | EP0804151B1 Lipophilic and amphiphilic film-forming polymer compositions, and use thereof in topical agents delivery system and method of delivering agents to the skin |
| 09/11/2002 | EP0769942B1 Use of a cationic amphipathic compound as a transfection agent, vaccine additive or drug |
| 09/11/2002 | EP0765159B1 Spin encapsulation apparatus and method of use |
| 09/11/2002 | EP0762870B1 Virosome-mediated intracellular delivery of therapeutic agents |
| 09/11/2002 | EP0758651B1 Crystal of pyrrolidylthiocarbapenem derivative, lyophilized preparation containing said crystal, and process for producing the same |
| 09/11/2002 | EP0757910B1 Percutaneously administrable base composition and percutaneously administrable drug composition prepared therefrom |
| 09/11/2002 | EP0665010B1 Method of manufacturing wax matrices |
| 09/11/2002 | CN1369011A Attenuated human-bovine chimeric parainfluenza virus (PIV) vaccines |
| 09/11/2002 | CN1368892A Sustained release formulation of peptide |
| 09/11/2002 | CN1368891A Moxilfloxacin formulation containing common salt |
| 09/11/2002 | CN1368890A Edible holographic products particularly pharmaceuticals and methods and apparatus for producing same |
| 09/11/2002 | CN1368889A Ocular tension lowering composition for topical admistration |
| 09/11/2002 | CN1368887A Mycophenolate Mofetil in association with PEG-IFN alpha |
| 09/11/2002 | CN1368880A Water-miscible pharmaceutical compositions of paclitaxel |
| 09/11/2002 | CN1368878A Drug therapy of restless leg syndrome |
| 09/11/2002 | CN1368877A Amphiphilic drug-oligomer conjugates with hydrolyzable lipophile components and methods for making and using the same |
| 09/11/2002 | CN1368876A Compositions and methods of treatment of attention deficit disorder and attention dificit/hyperactivity disorder with methylphenidate |
| 09/11/2002 | CN1368875A Supercritical fluid-assisted nebulization and bubble drying |
| 09/11/2002 | CN1368874A Implantable active ingredient depot |
| 09/11/2002 | CN1368503A Safflower lyochrome rich in carthamin A, its preparing process, its preparation and its medical usage |
| 09/11/2002 | CN1368370A Composite Chinese medicine applied via rectum and vagina musosa for gynopathy |
| 09/11/2002 | CN1368368A Nano medicine 'Xiaokening' and its preparing process |
| 09/11/2002 | CN1368367A Nano Medicine 'Zhixie' and its preparing process |
| 09/11/2002 | CN1368366A Nano medicine 'Jingwu' and its preparing process |
| 09/11/2002 | CN1368365A Nano medicine 'Dinggongteng' and its preparing process |
| 09/11/2002 | CN1368364A Nano medicine 'Hulusu' and its preparing process |
| 09/11/2002 | CN1368363A Nano emdicine 'Yaoxitong' and its preparing process |
| 09/11/2002 | CN1368362A Nano medicine for treating lumbocrural pain and its preparing process |
| 09/11/2002 | CN1368361A Nano medicine 'Xiaoer Jingan' and its preparing process |
| 09/11/2002 | CN1368360A Nano medicine for treating icteroheptitis and its preparing process |
| 09/11/2002 | CN1368359A Nano medicine 'Refined canthopanax Bark' and its preparing process |
| 09/11/2002 | CN1368358A Nano medicine 'Shenrong' and its preparing process |
| 09/11/2002 | CN1368357A Nano medicine 'Weitongding' and its preparing process |
| 09/11/2002 | CN1368356A Nano medicine 'Tianjingbushen' and its preparing process |
| 09/11/2002 | CN1368355A Nano medicine 'Suojing' and its preparing process |
| 09/11/2002 | CN1368354A Nano medicine 'Xinyi Biyan' and its preparing process |
| 09/11/2002 | CN1368353A Nano medicine 'Zibushengfa' and its preparing process |
| 09/11/2002 | CN1368352A Nano medicine 'Guanxinning' and its preparing process |
| 09/11/2002 | CN1368351A Nano medicine 'Hexue' and its preparing process |
| 09/11/2002 | CN1368350A Nano medicine 'Gutongling' and its preparing process |
| 09/11/2002 | CN1368349A Nano medicine 'Huodan Biyan' and its preparing process |
| 09/11/2002 | CN1368348A Nano medicine 'Jinhou' and its preparing process |
| 09/11/2002 | CN1368347A Nano medicine 'Jinjie' and its preparing process |
| 09/11/2002 | CN1368346A Nano emdicine 'Jiuerxin' and its preparing process |
| 09/11/2002 | CN1368345A Nano medicine 'Junliping' and its preparing process |
| 09/11/2002 | CN1368344A Nano medicine 'Kangfuling' and its preparing process |
| 09/11/2002 | CN1368343A Nano medicine 'Kanglebiyan' and its preparing process |
| 09/11/2002 | CN1368342A Nano medicine 'Dahuang Xiehuo' and its preparing process |
| 09/11/2002 | CN1368341A Nano medicine 'Pitong' and its preparing process |
| 09/11/2002 | CN1368340A Nano medicine 'Weiyi' and its preparing process |
| 09/11/2002 | CN1368339A Nano emdicine 'Wubishan' and its preparing process |
| 09/11/2002 | CN1368338A Nano medicine 'Quick-acting Xintong' and its preparing process |